Therefore, PI3K/Akt/mTOR signaling pathway has garnered much interest in NAFLD research but present results have not reached a consistent view on the role it played on NAFLD. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.